• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇生物合成与代谢在史密斯-勒米-奥皮茨综合征(SLOS)患者中导致医学复杂性的作用。

The role of cholesterol biosynthesis and metabolism causing medical complexity in patients with Smith-Lemli-Opitz Syndrome (SLOS).

作者信息

Elias Ellen Roy

机构信息

Pediatrics and Genetics, University of Colorado School of Medicine, Special Care Clinic, Children's Hospital Colorado, 13123 E 16th Ave, Aurora, CO 80045, United States.

出版信息

J Steroid Biochem Mol Biol. 2025 Nov;254:106822. doi: 10.1016/j.jsbmb.2025.106822. Epub 2025 Jul 1.

DOI:10.1016/j.jsbmb.2025.106822
PMID:40609800
Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive genetic disorder associated with complex anatomic abnormalities, accompanied by medical, developmental and behavioral challenges. It was the first human disorder identified to be caused by an error in the complex cholesterol biosynthetic pathway, more than thirty years ago. This review will cover the clinical and developmental phenotype of patients with SLOS, and the understanding of how cholesterol deficiency, accumulation of the cholesterol precursors 7- and 8-dehydrocholesterol (7-DHC and 8-DHC), and the oxidation of these precursors into toxic oxysterols, are now known to cause this complex phenotype. There is a wide range of severity in patients with SLOS. The most severely affected babies may be miscarried or die in the newborn period due to lethal congenital anomalies. The most mildly impacted patients may show few anatomic abnormalities other than 2-3 toe syndactyly, but still display cognitive and behavioral challenges along the autism spectrum. The review will also cover the medical evaluation and interventions which are recommended in caring for patients with SLOS. There is no cure for this devastating disease, but certain interventions can lead to an improved quality of life, and stabilization of progressive problems for these complex patients.

摘要

史密斯-勒米-奥皮茨综合征(SLOS)是一种常染色体隐性遗传疾病,与复杂的解剖学异常相关,同时伴有医学、发育和行为方面的问题。三十多年前,它是首个被确定由复杂胆固醇生物合成途径错误导致的人类疾病。本综述将涵盖SLOS患者的临床和发育表型,以及目前对胆固醇缺乏、胆固醇前体7-脱氢胆固醇和8-脱氢胆固醇(7-DHC和8-DHC)的积累,以及这些前体氧化为有毒氧化甾醇如何导致这种复杂表型的理解。SLOS患者的严重程度差异很大。受影响最严重的婴儿可能因致命的先天性异常而流产或在新生儿期死亡。受影响最轻的患者除了2-3趾并指外可能几乎没有解剖学异常,但仍会表现出自闭症谱系中的认知和行为问题。本综述还将涵盖在护理SLOS患者时推荐的医学评估和干预措施。这种毁灭性疾病无法治愈,但某些干预措施可以提高这些复杂患者的生活质量,并稳定其进行性问题。

相似文献

1
The role of cholesterol biosynthesis and metabolism causing medical complexity in patients with Smith-Lemli-Opitz Syndrome (SLOS).胆固醇生物合成与代谢在史密斯-勒米-奥皮茨综合征(SLOS)患者中导致医学复杂性的作用。
J Steroid Biochem Mol Biol. 2025 Nov;254:106822. doi: 10.1016/j.jsbmb.2025.106822. Epub 2025 Jul 1.
2
Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomes.胆酸在史密斯-勒米-奥皮茨综合征(SLOS)中的应用:真实世界患者的治疗结果
Orphanet J Rare Dis. 2025 Jul 28;20(1):381. doi: 10.1186/s13023-025-03914-x.
3
Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities.史密斯-勒米-奥皮茨综合征:临床、生化及遗传学见解与新出现的治疗机会
Genet Med. 2025 Jul;27(7):101450. doi: 10.1016/j.gim.2025.101450. Epub 2025 Apr 29.
4
Statins for Smith-Lemli-Opitz syndrome.他汀类药物治疗 Smith-Lemli-Opitz 综合征。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013521. doi: 10.1002/14651858.CD013521.pub2.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome.Smith-Lemli-Opitz 综合征患者脑脊液中神经胶质纤维酸性蛋白水平升高。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108570. doi: 10.1016/j.ymgme.2024.108570. Epub 2024 Aug 30.
7
Exploring Recent Developments in the Manifestation, Diagnosis, and Treatment of Patients with Smith-Lemli-Opitz Syndrome: From Molecular Pathways to Clinical Innovations.探索史密斯-勒米-奥皮茨综合征患者的临床表现、诊断和治疗的最新进展:从分子途径到临床创新
Int J Mol Sci. 2025 Jul 11;26(14):6672. doi: 10.3390/ijms26146672.
8
Altered Cerebrospinal Fluid Proteins in Smith-Lemli-Opitz Syndrome.史密斯-勒米-奥皮茨综合征中脑脊液蛋白质的改变
J Proteome Res. 2025 Aug 1;24(8):4154-4165. doi: 10.1021/acs.jproteome.5c00282. Epub 2025 Jul 9.
9
Homozygous DHCR7 p.Val330Met Variant Associated with Mild Non-Syndromic Intellectual Disability and Elevated Serum 7-Dehydrocholesterol Levels in Two Siblings.纯合子DHCR7 p.Val330Met变异与两名兄弟姐妹的轻度非综合征性智力障碍及血清7-脱氢胆固醇水平升高相关。
Genes (Basel). 2025 Jul 18;16(7):838. doi: 10.3390/genes16070838.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.